Advent Software, Inc. (NASDAQ:ADVS), a leading provider of software and services to the global investment management industry, announced that it will release its financial results for the first quarter ended March 31, 2014 on Monday, April 28, 2014 after the market closes. Advent Software, Inc. (NASDAQ:ADVS) shares after opening at $27.27 moved to $27.71 on last trade day and at the end of the day closed at $27.71. Company price to sales ratio in past twelve months was calculated as 3.72 and price to cash ratio as 42.14. Advent Software, Inc. (NASDAQ:ADVS) showed a negative weekly performance of -1.35%.
China XD Plastics Co Ltd (NASDAQ:CXDC) very impressive revenue growth greatly exceeded the industry average of 12.5%. Since the same quarter one year prior, revenues leaped by 79.4%. Growth in the company’s revenue appears to have helped boost the earnings per share. China XD Plastics Co Ltd (NASDAQ:CXDC) shares advanced 15.92% in last trading session and ended the day on $6.77. CXDC return on equity ratio is recorded as 26.90% and its return on assets is 10.70%. China XD Plastics Co Ltd (NASDAQ:CXDC) yearly performance is 60.81%.
Equities researchers at Oppenheimer decreased their price objective on shares of Comverse (NASDAQ:CNSI) from $44.00 to $36.00 in a research report issued on Wednesday, AmericanBankingNews.com reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target suggests a potential upside of 30.81% from the company’s current price. Comverse Inc. (NASDAQ:CNSI) shares moved down -3.71% in last trading session and was closed at $26.50, while trading in range of $26.36 – $27.76. Comverse Inc. (NASDAQ:CNSI) year to date (YTD) performance is -31.70%.
Apricus Biosciences, Inc. (NASDAQ:APRI) announced that Takeda Pharmaceuticals International GmbH, the Company’s partner in the United Kingdom, has accepted the first shipment of Vitaros, Apricus’ novel topical on-demand treatment for erectile dysfunction (“ED”). Apricus Biosciences Inc. (NASDAQ:APRI) weekly performance is 7.66%. On last trading day company shares ended up $2.39. Apricus Biosciences Inc. (NASDAQ:APRI) distance from 50-day simple moving average (SMA50) is 2.78%. Analysts mean target price for the company is $3.00.